Turkey's Ministry of Trade Reports: Nearly 6 Million Illegal E-Cigarettes Seized in 2024, Valued at $13 Million

Dec.31.2024
Turkey's Ministry of Trade Reports: Nearly 6 Million Illegal E-Cigarettes Seized in 2024, Valued at $13 Million
Turkey's Trade Minister Ömer Bolat revealed significant smuggling data for 2024, including seized vehicles, gold, tobacco products, and e-cigarettes.

According to a report from Tele1 on December 31, during a command and control assessment meeting at the Customs Protection General Directorate, Turkey's Minister of Trade, Ömer Bolat, revealed data on the smuggling of vehicles, gold, tobacco products, and e-cigarettes seized in 2024.


Borat pointed out that in 2024, authorities seized illicit tobacco products worth 917 million lira (26 million dollars) in 2173 cases. Additionally, in 2024, Turkey confiscated over 5.952 million e-cigarette devices and their accessories valued at 469 million lira (13 million dollars).


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

RLX Technology Inc. (NYSE: RLX) Q3 2025 Financial Results: Net Revenue US$158.6 Million; International Business Accounts for 72%
RLX Technology Inc. (NYSE: RLX) Q3 2025 Financial Results: Net Revenue US$158.6 Million; International Business Accounts for 72%
RLX Technology Inc. (NYSE: RLX) announced its unaudited financial results for the third quarter of 2025. The company reported net revenue of RMB 1.13 billion, up 49.3% year-on-year, and adjusted net profit of RMB 295.4 million, up 1.4% quarter-on-quarter. International business contributed 72% of total revenue, reflecting robust financial performance and continued shareholder returns.
Nov.14
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
Thailand's Senate and House of Representatives have different stances on e-cigarettes: the Senate advocates a ban on sales, while the House of Representatives proposes legalization and regulation
Thailand's Senate and House of Representatives have different stances on e-cigarettes: the Senate advocates a ban on sales, while the House of Representatives proposes legalization and regulation
Recently, the Thai Senate and House of Representatives submitted research reports on e-cigarettes, but their positions were completely opposite. The report of the Senate Public Health Committee insisted on maintaining a complete ban on the import and sale of e-cigarettes, emphasizing the protection of public health, especially youth health, while the report of the House of Representatives Special Committee proposed to legalize e-cigarettes under a strict regulatory framework.
Sep.25 by 2FIRSTS.ai
Thailand to Establish Inter-Agency Committee to Strengthen E-Cigarette Enforcement
Thailand to Establish Inter-Agency Committee to Strengthen E-Cigarette Enforcement
The Thai government will establish an inter-agency committee under the Prime Minister’s Office to address the rapid spread of e-cigarettes among youth. Deputy Prime Minister Sophon Sarum said the fragmented enforcement across multiple laws and agencies has created gaps. The new mechanism will coordinate enforcement, report directly to the Cabinet, and propose legal amendments if current laws are insufficient.
Nov.20 by 2FIRSTS.ai
UK plans law to license vape retailers; unlicensed sales could face heavy fines
UK plans law to license vape retailers; unlicensed sales could face heavy fines
The UK plans a national licensing regime for vape and tobacco sales, making unlicensed retail illegal, and will consult experts on flavours, nicotine strength, packaging and design.
Oct.09 by 2FIRSTS.ai
Al Fakher Parent Company Plans U.S. Listing in 2026 at $1.75 Billion Valuation
Al Fakher Parent Company Plans U.S. Listing in 2026 at $1.75 Billion Valuation
According to Bloomberg, Dubai-based hookah brand owner Advanced Inhalation Rituals (AIR) plans to go public on Nasdaq in the first half of 2026 through a merger with a Cantor Fitzgerald-backed SPAC. The deal values the combined company at USD 1.75 billion under the ticker “AIIR.”
Nov.11